Humanetics Corp
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1700 W Hwy 36 Ste 360, Roseville, Minnes...Website
www.humaneticscorp.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Humanetics Corp
Humanetics Corporation specializes in developing innovative treatments for solid tumor cancers, focusing on improving patient outcomes during radiation therapy. Their flagship product, BIO 300, is designed to enhance the efficacy of cancer treatments while also addressing inflammatory lung diseases and providing medical countermeasures against radiation injuries. The company targets oncology patients, healthcare providers, and defense sectors, aiming to protect civilians and military personnel from nuclear threats. With a commitment to advancing cancer care and public safety, Humanetics is actively involved in clinical trials and collaborations to further their mission.Explore more
Humanetics Corp Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Humanetics Corp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Humanetics Corp, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Humanetics Corp launches new products
Congratulate Masked Content for being promoted to Masked Content at Humanetics Corp
Website visits: Recent activity has been detected on your website
Check out if Humanetics Corp is spiking on competitors!
Check if Humanetics Corp has recently received funding, and reach out quickly before it becomes old news!
Click to see if Humanetics Corp had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Humanetics Corp has new funding data
Earning: See what the market has to say on Humanetics Corp recently announced quarterly report
Recommended Actions
Find VP level buyers at Humanetics Corp
Find 2 more new buyers
Compare Similar Companies to Humanetics Corp
Compare insights from companies similar to Humanetics Corp, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$21.9M
51-200
Private
-
1992
ML
Michael LyttonGroup Executive VP-Corp Development and Strategy and Gen Manager
Company Profile Activity
Activity Insights
Humanetics Corp is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Humanetics Corp is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Humanetics Corp.
Humanetics Corp financials insights
Gather financial insights about Humanetics Corp, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$125K
Humanetics Corp Tech Stack
A closer look at the technologies used by Humanetics Corp
Most Recent Scoops
New Hire
Executive Move
Timothy Morris has recently joined the organization as Chief Operating Officer.
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
Project
Award, Spending/Investment
Executive Move
Board of Directors
New Hire
Executive Move
Humanetics Corp News & Media
Humanetics Corporation to Present at Upcoming Military Medical and Defense Conferences
MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company pioneering novel prophylactic Medical Countermeasures for warfighters, first responders, and others at risk of radiation exposure from nuclear attacks or industrial accidents, today announced that Company scientists and members of the leadership team will be presenting and participating at the following conferences and events: Countering Weapons of Mass Destruction (CWMD) ConsortiumHumanetics Corporation to Participate in Benchmark Healthcare Investor Conference This Week
MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation announced today that executive management team members will participate in the Benchmark Company’s 5th Annual Healthcare House Call Virtual Investor Conference this week. The conference takes place on Thursday, May 29th, and Humanetics will be featured during the 1:30 – 2:10 ET time slot. About Humanetics Corporation Humanetics is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercializationHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)Humanetics Corporation Chief Medical Officer Is Featured Guest at U.S. Industry, National Security, and Healthcare Forum
MINNEAPOLIS--(BUSINESS WIRE)--BIO 300 will be the subject of a presentation at a U.S. industry, national security, and healthcare forum on February 27th, 2025.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Humanetics Corp
Sign Up For FreeTo access detailed company insights
Humanetics Corporation specializes in developing innovative treatments for solid tumor cancers, focusing on improving patient outcomes during radiation therapy. Their flagship product, BIO 300, is designed to enhance the efficacy of cancer treatments while also addressing inflammatory lung diseases and providing medical countermeasures against radi... Read More
